The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma.

Autor: Morgado-Palacin L; Institute for Cancer Genetics, Columbia University, New York, NY, USA., Brown JA; Institute for Cancer Genetics, Columbia University, New York, NY, USA., Martinez TF; Department of Pharmaceutical Sciences, University of California, Irvine, CA, USA., Garcia-Pedrero JM; Department of Otolaryngology, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.; Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, Madrid, Spain., Forouhar F; Proteomics and Macromolecular Crystallography Shared Resource, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA., Quinn SA; Institute for Cancer Genetics, Columbia University, New York, NY, USA., Reglero C; Institute for Cancer Genetics, Columbia University, New York, NY, USA., Vaughan J; Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA., Heydary YH; Department of Pharmaceutical Sciences, University of California, Irvine, CA, USA., Donaldson C; Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA., Rodriguez-Perales S; Molecular Cytogenetics Group, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029, Madrid, Spain., Allonca E; Department of Otolaryngology, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.; Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, Oviedo, Spain., Granda-Diaz R; Department of Otolaryngology, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.; Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, Madrid, Spain., Fernandez AF; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.; Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, Oviedo, Spain.; Cancer Epigenetics and Nanomedicine Laboratory, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), El Entrego, Spain.; Department of Organisms and Systems Biology (B.O.S.), University of Oviedo, Oviedo, Spain.; Rare Diseases CIBER (ciberer) of the Carlos III Health Institute (ISCIII), Madrid, Spain., Fraga MF; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.; Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, Oviedo, Spain.; Cancer Epigenetics and Nanomedicine Laboratory, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), El Entrego, Spain.; Department of Organisms and Systems Biology (B.O.S.), University of Oviedo, Oviedo, Spain.; Rare Diseases CIBER (ciberer) of the Carlos III Health Institute (ISCIII), Madrid, Spain., Kim AL; Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA., Santos-Juanes J; Department of Dermatology, Hospital Universitario Central de Asturias (HUCA), Oviedo, Asturias, Spain.; Dermatology Area, University of Oviedo Medical School, Oviedo, Asturias, Spain., Owens DM; Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA.; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA., Rodrigo JP; Department of Otolaryngology, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.; Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, Madrid, Spain., Saghatelian A; Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA., Ferrando AA; Institute for Cancer Genetics, Columbia University, New York, NY, USA. af2196@columbia.edu.; Dermatology Area, University of Oviedo Medical School, Oviedo, Asturias, Spain. af2196@columbia.edu.; Department of Systems Biology, Columbia University, New York, NY, USA. af2196@columbia.edu.

Publikováno v: Nature communications [Nat Commun] 2023 Mar 10; Vol. 14 (1), pp. 1328. Date of Electronic Publication: 2023 Mar 10.